Volume 11| December 4, 2018
RxReins is a dedicated Managing General Underwriter (MGU) specializing in prescription stop loss insurance for group benefit plans. We work closely with Brokers, TPAs and PBMs to provide the best available products from multiple A-rated carriers in all fifty states . RxReins is a member of the ELMC Risk Solutions family of companies.
MONTHLY NEWS AND UPDATES!
Four Policy Solutions That Would Bring Fairness to Drug Pricing

"Other than the grip that the pharmaceutical industry has on Congress and our state legislatures primarily through their lobbying and control of regulatory bodies, pragmatic fixes to the US drug cost crisis are not that elusive. Here are four straightforward policy solutions that would bring fairness to US drug pricing and parity with other industrialized countries ."

FDA Approves First Biosimilar for Treatment of Adult Patients with Non-Hodgkin’s Lymphoma

"FDA approved Truxima (rituximab-abbs) as the first biosimilar to Rituxan (rituximab) for the treatment of adult patients with CD20-positive, B-cell non-Hodgkin’s lymphoma (NHL) to be used as a single agent or in combination with chemotherapy.As part of the FDA's Biosimilars Action Plan we’re advancing new policies to make the development of biosimilars more efficient and to enable more opportunities for biosimilar manufacturers to make these products commercially successful and competitive ."

Shortening Hepatitis C Treatment Feasible in Half of Patients

"New research suggests that hepatitis C virus (HCV) treatments can be shortened in half of patients receiving them without compromising efficacy, potentially leading to significant cost savings . An estimated 70 million individuals worldwide are chronically infected with HCV. Although the disease is curable, direct acting anti-viral (DAA) drugs used to treat HCV can be costly, ranging between $40,000 and $100,000. Despite advancements in treating HCV, cost and access remain a significant barrier for many patients ."

Why You Should Carve Out in 2019?

  1. Reduce your overall Stop Loss Premium.
  2. Lower your risk exposure.
  3. Reduce attachment point with a managed Rx Plan.

Click the link below, to learn more about our Carve-Out Concept
RxReins, LLC | 888.797.3467 | Stoploss@Rxreins.coml | www.rxreins.com